About GQ Life Sciences
GQ Life Sciences is a company based in Alpharetta (United States) founded in 2001 was acquired by Aptean in October 2016. GQ Life Sciences has raised $11.2 million across 3 funding rounds from investors including Société Générale, Aptean and Cross Atlantic Capital Partners. The company has 16 employees as of December 31, 2022. GQ Life Sciences offers products and services including LifeQuest and GenomeQuest. GQ Life Sciences operates in a competitive market with competitors including Human Longevity, Helix, Benchling, Genuity Science and Inpharmatica, among others.
- Headquarter Alpharetta, United States
- Employees 16 as on 31 Dec, 2022
-
Sectors
Professional & Legal ServicesHealthcare Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genomequest, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.2 M (USD)
in 3 rounds
-
Latest Funding Round
$3.1 M (USD), Series A
Dec 15, 2009
-
Investors
Société Générale
& 5 more
-
Employee Count
16
as on Dec 31, 2022
-
Acquired by
Aptean
(Oct 03, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GQ Life Sciences
GQ Life Sciences offers a comprehensive portfolio of products and services, including LifeQuest and GenomeQuest.
Platform for patent searches using biological sequences and queries
Tool for comprehensive life science patent analysis and research
Funding Insights of GQ Life Sciences
GQ Life Sciences has successfully raised a total of $11.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.1 million completed in December 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GQ Life Sciences
GQ Life Sciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Société Générale, Aptean and Cross Atlantic Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early to mid-stage US companies.
|
Locked | Locked | Locked | |
|
Growth & late stage life sciences and tech focused venture capital firm funding companies in the US
|
Locked | Locked | Locked | |
|
Early-stage venture capital is provided by Activate Venture Partners.
|
Locked | Locked | Locked |
Investor details for GQ Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GQ Life Sciences
Investment portfolio details for GQ Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GQ Life Sciences
Detailed financials for GQ Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gq Life Sciences Comparisons
Peer comparison for GQ Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GQ Life Sciences
GQ Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, Helix, Benchling, Genuity Science and Inpharmatica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
Detailed competitors of GQ Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gq Life Sciences
Complete news archive for GQ Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GQ Life Sciences
GQ Life Sciences was founded in 2001 and raised its 1st funding round 4 years after it was founded.
GQ Life Sciences is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
GQ Life Sciences is a funded company, having raised a total of $11.2M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at GQ Life Sciences is 16.
GQ Life Sciences was founded in 2001 and is headquartered in Alpharetta, United States. Tools for life science research are developed by the company within the biotechnology sector. A patent search platform known as LifeQuest is provided, utilizing semantic analysis and life science ontology keywords. Additionally, GenomeQuest is maintained as a curated database of DNA, RNA, and protein sequences sourced from public and proprietary patent records.
GQ Life Sciences's top competitors include Helix, Human Longevity and Benchling.
GQ Life Sciences offers LifeQuest and GenomeQuest.
GQ Life Sciences has 6 investors. Key investors include Société Générale, Aptean, Cross Atlantic Capital Partners, Mosaix Ventures, and Activate Venture Partners.